Nearly $23 Million to Battle Deadly Fungal Infections

Fungi can heal, connect, and sustain—but some species kill. A new almost 23 million USD (£17.9M) initiative led by the University of Dundee, Exeter, and GSK is targeting two lethal fungal pathogens: Cryptococcus neoformans and Candida auris. Both are devastating for immunocompromised patients and rising as climate-linked threats. Over five years, the project aims to deliver two pre-clinical antifungal drug candidates with broad-spectrum potential—reshaping global fungal medicine and turning the tide against resistance.










